Jobs / United States / Abbvie US LLC

Abbvie US LLC

Associate Director, HEOR Strategy, Specialty

Mettawa, IL, US Posted 4 days ago

Apply on employer site ↗ Tailor my CV first Source: Company careers site

Optional: we can tailor a CV and cover letter for this job from your real experience first (the first one is free).

Skills this job asks for

LeadershipProduct managementTranslationCommunication

Add your CV (free) to see which of these your CV is missing.

Sponsorship verdict

Sponsorship possible

One solid signal, not two. Worth applying, and worth asking about sponsorship early.

  • Employer is on a government sponsor recordThe US Department of Labor certified 177 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
  • The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
  • No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
  • What Abbvie US LLC paid sponsored hires in similar roles1 certified filing for “ASSOCIATE DIRECTOR, RA GLOBAL REGULATORY STRATEGY” (Regulatory Affairs Managers) in IL: $185k–$185k, median $185k.
  • Confirmed live todayWhen a source last listed this job as open.
Details and sources
Employer is on a government sponsor record
The US Department of Labor certified 177 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
No salary bar for this route
H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
What Abbvie US LLC paid sponsored hires in similar roles
1 certified filing for “ASSOCIATE DIRECTOR, RA GLOBAL REGULATORY STRATEGY” (Regulatory Affairs Managers) in IL: $185k–$185k, median $185k. Most were filed at wage level II (100%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).

US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).

A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.

About the role

The Associate Director, Health Economics & Outcomes Research (HEOR) Strategy, Specialty will serve as the strategic HEOR lead for assigned assets within the Hypothyroidism Therapeutic Area. The role will develop and advance integrated evidence strategies supporting launch readiness, value demonstration, market access, differentiation, and lifecycle management, partnering across the Integrated Brand Team and broader organization to inform asset and business decisions. As an individual contributor, the Associate Director will provide strategic and scientific leadership while leveraging V&E Centers of Excellence (COEs) and research partners for technical execution. The successful candidate will demonstrate strong strategic judgment, cross-functional influence, and leadership potential to assume broader responsibilities over time. Responsibilities • Develop and evolve the integrated HEOR evidence strategy and roadmap , translating business, clinical, patient, and access evidence gaps into prioritized research initiatives aligned with asset strategy, launch milestones, and stakeholder needs. • Provide strategic and scientific direction across evidence-generation initiatives, including real-world evidence (RWE), patient and healthcare professional research, patient-reported outcomes, burden-of-illness and comparative-effectiveness research, and economic modeling. • Partner with V&E Centers of Excellence (COEs) and research partners to ensure methodological rigor, strategic alignment, prioritization, and timely evidence delivery while providing strategic direction and oversight . • Represent HEOR as a trusted strategic partner on cross-functional asset and launch teams, connecting insights across Commercial Marketing, Market Access, MHI/Value & Evidence, Clinical Development, Regulatory, and other relevant functions to inform integrated asset decisions. • Integrate and translate clinical, economic, humanistic, societal, and patient-centered evidence into a cohesive value narrative with clear implications for scientific, access, and business decision-making. • Anticipate changes in the payer, reimbursement, HTA, policy, and value-assessment environment and communicate implications, opportunities, risks, and recommendations to senior leaders and cross-functional decision-making forums. • Demonstrate leadership through influence, curiosity, and an enterprise mindset , using sound judgment and creativity to connect perspectives, build alignment, make timely decisions, and deliver in a fast-paced, ambiguous, and evolving environment . • Advanced degree in health economics or a related discipline, with a minimum of 5 years of relevant experience for candidates with a Master’s degree or a minimum of 3 years of relevant experience for candidates with a PhD or other relevant doctoral degree (e.g., PharmD, MD). • Strong knowledge of HEOR methodologies , with experience in areas such as RWE and observational research, patient-reported outcomes, economic modeling, burden-of-illness, comparative effectiveness, patient and healthcare professional research, and/or evidence synthesis. • Demonstrated ability to translate asset, business, patient, and stakeholder needs into strategic evidence priorities and actionable research questions . • Experience supporting asset, brand, pipeline, and/or launch strategy , preferably for a pre-launch or launch-stage pharmaceutical asset. • Experience developing and translating evidence to support value demonstration, payer, market access, formulary, and reimbursement decision-making , with an understanding of the US payer and relevant HTA environment. • Proven ability to lead through influence , leverage technical experts and execution partners, and build alignment across complex cross-functional teams wi

Apply on employer site ↗